Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists.
clinic utilization
clinical pharmacy
clinical pharmacy specialists
marketing
pharmacists
pharmacy administration
Journal
The mental health clinician
ISSN: 2168-9709
Titre abrégé: Ment Health Clin
Pays: United States
ID NLM: 101728585
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
15
4
2021
Statut:
epublish
Résumé
This quality improvement initiative aimed to implement a strategy to increase access to care with clinical pharmacy specialists (CPSs), optimize CPS direct patient care activities, and promote clinical pharmacy services. The primary objective was to assess the impact of patient marketing on expanding access to care and clinic utilization in a CPS clinic. A marketing technique was applied by a mental health (MH) CPS to expand clinical pharmacy services. Direct-to-patient brochures advertising MH CPS comprehensive medication management services were placed at the check-in window of an interdisciplinary outpatient MH clinic. Brochure content included a description of an MH team, the role of MH CPSs, and benefits of being managed by MH CPSs. Patients could contact the MH CPS or speak to their primary provider for referral. The preintervention and postintervention evaluation periods were 4-month time frames. Clinic utilization for the MH CPS clinic was compared before and after dissemination of marketing brochures. Additional outcomes evaluated were number of encounters, number of patients seen, and number of clinical interventions completed by the MH CPS. There was a significant increase in clinic utilization postintervention. The total number of encounters, patients, and clinical interventions were numerically increased postintervention. The observed improvements in clinic utilization suggest the benefit of marketing in optimization of access to care in CPS clinics and justification of clinical pharmacy services.
Identifiants
pubmed: 33850684
doi: 10.9740/mhc.2021.03.059
pii: MHC-D-20-00076
pmc: PMC8019546
doi:
Types de publication
Journal Article
Langues
eng
Pagination
59-63Informations de copyright
© 2021 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists.
Déclaration de conflit d'intérêts
Disclosures: The authors declare no relevant conflicts of interest or financial relationships. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Portions of the results have been presented previously in abstract form at the 2020 American College of Clinical Pharmacy Virtual Poster Symposium.
Références
Ment Health Clin. 2018 Apr 26;8(3):105-109
pubmed: 29955554
Am J Health Syst Pharm. 2002 Aug 15;59(16):1518-26
pubmed: 12185826
J Med Life. 2019 Apr-Jun;12(2):93-96
pubmed: 31406509
J Am Pharm Assoc (2003). 2009 May-Jun;49(3):383-91
pubmed: 19357068
J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):203-214
pubmed: 18359733
J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):173-84
pubmed: 12688435
Pharmacotherapy. 2008 Feb;28(2):285
pubmed: 18225974